Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trials
Cystoid macular edema (CME) is a relatively common painless condition usually accompanied by blurred vision. The prevalence of CME varied from 5% to 47% depending on cause of pathology. There are several treatments available for ME including intravitreal use of bevacizumab that has been used in diff...
Main Author: | Hammad A Qazi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2012-01-01
|
Series: | Journal of Research in Medical Sciences |
Subjects: | |
Online Access: | http://www.jmsjournal.net/article.asp?issn=1735-1995;year=2012;volume=17;issue=12;spage=1180;epage=1187;aulast=Qazi |
Similar Items
-
Intravitreal Avastin for managing CNV due to age-related macular degeneration
by: Quan - Liang Zhao, et al.
Published: (2013-05-01) -
Effects of intravitreal bevacizumab injection on the clinical manifestations of nonproliferative diabetic retinopathy in patients with macular edema: a systematic review
by: Touka Banaee, et al.
Published: (2016-04-01) -
Pretreatment Clinical Variables Associated With the Response to Intravitreal Bevacisumab (Avastin) Injection In Patients With Persistent Diabetic Macular Edema
by: Fareed A. Warid AL-Laftah, et al.
Published: (2010-07-01) -
VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
by: Saquib Naeem, et al.
Published: (2019-04-01) -
Multidose bevacizumab (Avastin) vial microbial safety: A real-life scenario
by: Battu Aneesha Priya, et al.
Published: (2021-01-01)